Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies

The prosocial neuropeptide oxytocin is being developed as a potential treatment for various neuropsychiatric disorders including autism spectrum disorder (ASD). Early studies using intranasal oxytocin in patients with ASD yielded encouraging results and for some time, scientists and affected familie...

Descripción completa

Detalles Bibliográficos
Autores principales: Althammer, Ferdinand, Muscatelli, Francoise, Grinevich, Valery, Schaaf, Christian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360032/
https://www.ncbi.nlm.nih.gov/pubmed/35941105
http://dx.doi.org/10.1038/s41398-022-02054-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360032/
https://www.ncbi.nlm.nih.gov/pubmed/35941105
http://dx.doi.org/10.1038/s41398-022-02054-1

Ejemplares similares